| parent | Antitubercular agents | LP31463-0 |
| child | rifAMPin 1.0 ug/mL | LP229502-2 |
| child | rifAMPin | Isolate | Antibiotic susceptibilities | LP380420-2 |
| child | rifAMPin | Isolate and Serum | Antibiotic susceptibilities | LP380422-8 |
| child | rifAMPin 2.0 ug/mL | LP229504-8 |
| child | rifAMPin 5.0 ug/mL | LP229506-3 |
| child | rifAMPin 14.0 ug/mL | LP229503-0 |
| child | rifAMPin 40.0 ug/mL | LP229505-5 |
| parent | Antitubercular agents | LP31463-0 |
| child | rifAMPin | DBS | Drug toxicology | LP389131-6 |
| child | rifAMPin | Serum or Plasma | Drug toxicology | LP389132-4 |
| parent | Antitubercular agents | LP31463-0 |
| child | rifAMPin | Dose | Drug doses | LP392225-1 |
| PartDisplayName | en-US | rifAMPin |
| DisplayName | en-US | rifAMPin |
LOINC Version: 2.80
FHIR